Ann Intern Med:ACP公布心脏病患者贫血治疗指南

2013-12-06 高晓方 译 医学论坛网

美国内科医师学会(ACP)于近日公布了心脏病患者贫血和铁缺乏治疗指南。此项指南以贫血和铁缺乏英文文献为基础,评估转归包括死亡、住院、运动耐量、生活质量和心血管事件(心梗、充血性心衰加重、心律失常或心源性死亡),以及包括高血压、静脉血栓栓塞事件和缺血性脑血管事件在内的损害。以下为两项摘要中的推荐: 推荐1: 在冠心病住院患者中,ACP推荐应用限制性红细胞输注策略(血红蛋白触发阈值为7~


美国内科医师学会(ACP)于近日公布了心脏病患者贫血和铁缺乏治疗指南。此项指南以贫血和铁缺乏英文文献为基础,评估转归包括死亡、住院、运动耐量、生活质量和心血管事件(心梗、充血性心衰加重、心律失常或心源性死亡),以及包括高血压、静脉血栓栓塞事件和缺血性脑血管事件在内的损害。以下为两项摘要中的推荐:

推荐1: 在冠心病住院患者中,ACP推荐应用限制性红细胞输注策略(血红蛋白触发阈值为7~8 g/dL;弱推荐,低质量证据)。

推荐2: 在同时伴轻、中度贫血以及充血性心衰或冠心病的患者中,ACP反对应用促红细胞生成素(强推荐,中等质量证据)。全文12月3日在线发表于《内科学年鉴》[Ann Intern Med. 2013, 159(11):770]。

原文出处:

Amir Qaseem, MD, PhD, MHA; Linda L. Humphrey, MD, MPH; Nick Fitterman, MD; Melissa Starkey, PhD; Paul Shekelle, MD, PhD, for the Clinical Guidelines Committee of the American College of Physicians.Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians.Ann Intern Med. 2013;159(11):770-779. doi:10.7326/0003-4819-159-11-201312030-00009【原文下载】


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1746511, encodeId=126b1e4651193, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jul 10 21:18:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934757, encodeId=a7381934e578e, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Sat Mar 15 23:18:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606065, encodeId=36471606065b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 08 04:18:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]
    2014-07-10 waiwai3042
  2. [GetPortalCommentsPageByObjectIdResponse(id=1746511, encodeId=126b1e4651193, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jul 10 21:18:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934757, encodeId=a7381934e578e, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Sat Mar 15 23:18:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606065, encodeId=36471606065b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 08 04:18:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1746511, encodeId=126b1e4651193, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jul 10 21:18:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934757, encodeId=a7381934e578e, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Sat Mar 15 23:18:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606065, encodeId=36471606065b2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 08 04:18:00 CST 2013, time=2013-12-08, status=1, ipAttribution=)]